Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome

Year: 1396
COI: JR_IJBMS-20-5_014
Language: EnglishView: 35
This Paper With 12 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 12 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Jamshid Tabeshpour - Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Mohsen Imenshahidi - Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Hossein Hosseinzadeh - Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract:

Metabolic syndrome (MetS), characterized by a cluster of metabolic abnormalities including hypertension, obesity, type ۲ diabetes mellitus (T۲DM) and dyslipidemia, is a well-known cardiovascular risk factor (CVRF). Cardiovascular disease (CVD) represents a massive healthcare burden worldwide. In recent years, with regard to the adverse effects of synthetic drugs, increasing attention has been paid by researchers to herbal medicines for a variety of disorders such as CVD. A large body of literature supports different pharmacological actions of Berberis vulgaris (B. vulgaris) and its active component, berberine (BBR), such as antidiabetic, antiobesity, hypotensive and hypolipidemic properties that could be interesting in the management of MetS associated with high CVD risk. Numerous preclinical in vitro and in vivo studies support all these effects. In this review, we evaluated the most related original articles to discover the role of B. vulgaris on various constituents of MetS and CVRF comprising dyslipidemia, obesity, high blood pressure and high blood glucose. This review suggests a potential role of B. vulgaris and BBR in the managing of MetS; nevertheless more investigations, especially reliable clinical trials, need to be accomplished to evaluate their effectiveness.

Keywords:

Paper COI Code

This Paper COI Code is JR_IJBMS-20-5_014. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1295732/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Tabeshpour, Jamshid and Imenshahidi, Mohsen and Hosseinzadeh, Hossein,1396,A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome,https://civilica.com/doc/1295732

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • Reaven GM. Role of insulin resistance in human disease. Diabetes ...
  • DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible ...
  • Lemieux I, Pascot A, Couillard C, Lamarche Bt, Tchernof A, ...
  • Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, ...
  • Grundy SM, Hansen B, Smith SC, Cleeman JI, Kahn RA, ...
  • Alberti KGM, Zimmet P, Shaw J, Group IETFC. The metabolic ...
  • Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, ...
  • Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, ...
  • Mamikutty N, Thent ZC, Sapri SR, Sahruddin NN, Mohd Yusof ...
  • O'Flaherty M, Buchan I, Capewell S. Contributions of treatment and ...
  • Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of ...
  • Shrivastava R, Agrawal R, Parveen Z. A review on therapeutic ...
  • Akaberi M, Hosseinzadeh H. Grapes (Vitis vinifera) as a potential ...
  • Razavi BM, Hosseinzadeh H. A review of the effects of ...
  • Hosseinzadeh H, Nassiri-Asl M. Review of the protective effects of ...
  • Hosseini A, Hosseinzadeh H. A review on the effects of ...
  • Rounsaville TJ, Ranney TG. Ploidy levels and genome sizes of ...
  • Kafi M, Balendari A. Berberis Production and Processing. Ferdowsi University ...
  • Mokhber-Dezfuli N, Saeidnia S, Gohari AR, Kurepaz-Mahmoodabadi M. Phytochemistry and ...
  • Drofler H, Roselt G. The dictionary of healing plants. New ...
  • Arayne MS, Sultana N, Bahadur SS. The berberis story: Berberis ...
  • Tomosaka H, Chin Y-W, Salim AA, Keller WJ, Chai H, ...
  • Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis ...
  • Hajzadeh M, Rajaei Z, Shafiee S, Alavinejhad A, Samarghandian S, ...
  • Potdar D, Hirwani RR, Dhulap S. Phyto-chemical and pharmacological applications ...
  • Nassiri-Asl M, Hosseinzadeh H, Mortazavi SR. Effects of Berberis vulgaris ...
  • Imenshahidi M, Qaredashi R, Hashemzaei M, Hosseinzadeh H. Inhibitory effect ...
  • Mohammadi A, Sahebkar A, Kermani T, Zhilaee M, Tavallaie S, ...
  • Gorval LM, Grishkovets VI. Alkaloids of some species of the ...
  • Amin AH, Subbaiah TV, Abbasi KM. Berberine sulfate: antimicrobial activity, ...
  • Ni W-J, Ding H-H, Tang L-Q. Berberine as a promising ...
  • Yin J, Xing H, Ye J. Efficacy of berberine in ...
  • Cui G, Qin X, Zhang Y, Gong Z, Ge B, ...
  • Freile ML, Giannini F, Pucci G, Sturniolo A, Rodero L, ...
  • Wang N, Feng Y, Zhu M, Tsang C-M, Man K, ...
  • Goff DC, Jr., Bertoni AG, Kramer H, Bonds D, Blumenthal ...
  • Gulati OP. Pycnogenol® in metabolic syndrome and related disorders. Phytother ...
  • Dong S-F, Hong Y, Liu M, Hao Y-Z, Yu H-S, ...
  • Kong W, Wei J, Abidi P, Lin M, Inaba S, ...
  • Kong W-J, Wei J, Zuo Z-Y, Wang Y-M, Song D-Q, ...
  • Taheri S, Zarei A, Changizi Ashtiyani S, Rezaei A, Zaheiri ...
  • Wang Y, Yi X, Ghanam K, Zhang S, Zhao T, ...
  • Chang X, Yan H, Fei J, Jiang M, Zhu H, ...
  • Zhou Y, Cao S, Wang Y, Xu P, Yan J, ...
  • Zhao W, Xue R, Zhou Z-X, Kong W-J, Jiang J-D. ...
  • Mazza A, Lenti S, Schiavon L, Zuin M, D’Avino M, ...
  • Zhu L, Li H. Therapeutic efficacy of combined Berberine and ...
  • Shanobin J, Lirong T, Yi S. Interventioal effect of berberine ...
  • Brusq J-M, Ancellin N, Grondin P, Guillard R, Martin S, ...
  • Grover SA, Kaouache M, Rempel P, Joseph L, Dawes M, ...
  • El-Sayed MM, Ghareeb DA, Talat HA, Sarhan EM. High fat ...
  • Hu Y, Davies GE. Berberine inhibits adipogenesis in high-fat diet-induced ...
  • Iloon Kashkooli R, Najafi SS, Sharif F, Hamedi A, Hoseini ...
  • World Health Organization. Prevention of cardiovascular disease: guideline for assessment ...
  • Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes ...
  • Guo Z, Sun H, Zhang H, Zhang Y. Anti-hypertensive and ...
  • Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, Fatehi M. The antihypertensive ...
  • Chun YT, Yip TT, Lau KL, Kong YC, Sankawa U. ...
  • Kang DG, Sohn EJ, Kwon EK, Han JH, Oh H, ...
  • Huang WM, Yan H, Jin JM, Yu C, Zhang H. ...
  • Marin-Neto JA, Maciel BC, Secches AL, Gallo Junior L. Cardiovascular ...
  • Trimarco V, Cimmino C, Santoro M, Pagnano G, Manzi M, ...
  • Pang B, Zhao L-H, Zhou Q, Zhao T-Y, Wang H, ...
  • Gu Y, Zhang Y, Shi X, Li X, Hong J, ...
  • García-Fontana B, Morales-Santana S, Díaz Navarro C, Rozas-Moreno P, Genilloud ...
  • Abd El-Wahab A, Ghareeb D, Sarhan E, Abu-Serie M, El ...
  • Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S, ...
  • Zhang H, Wei J, Xue R, Wu J-D, Zhao W, ...
  • Zhang Y, Li X, Zou D, Liu W, Yang J, ...
  • Lan J, Zhao Y, Dong F, Yan Z, Zheng W, ...
  • Zhang M, Lv X, Li J, Meng Z, Wang Q, ...
  • Zhou J, Zhou S, Tang J, Zhang K, Guang L, ...
  • Chatuphonprasert W, Lao-ong T, Jarukamjorn K. Improvement of superoxide dismutase ...
  • Zhang Q, Xiao X, Feng K, Wang T, Li W, ...
  • Lu S-S, Yu Y-L, Zhu H-J, Liu X-D, Liu L, ...
  • Cicero AF, Tartagni E. Antidiabetic properties of berberine: from cellular ...
  • Chang W, Zhang M, Li J, Meng Z, Wei S, ...
  • Ko B-S, Choi SB, Park SK, Jang JS, Kim YE, ...
  • Pan G-Y, Huang Z-J, Wang G-J, Fawcett JP, Liu X-D, ...
  • Lou T, Zhang Z, Xi Z, Liu K, Li L, ...
  • Yin J, Gao Z, Liu D, Liu Z, Ye J. ...
  • Jeong HW, Hsu KC, Lee J-W, Ham M, Huh JY, ...
  • Han J, Lin H, Huang W. Modulating gut microbiota as ...
  • Changizi Ashtiyani S, Zarei A, Taheri S, Rezaei A, Golshan ...
  • Zheng B, Wei J, Jiang J, GONG H-h, ZHANG R-s. ...
  • Ye W. Clinical efficacy of berberine treatment of diabetes. Mod ...
  • JANG C-S. The action of berberine on mammalian hearts. J ...
  • Kong W-J, Zhang H, Song D-Q, Xue R, Zhao W, ...
  • Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, ...
  • Liu C, Wang Z, Song Y, Wu D, Zheng X, ...
  • Di Pierro F, Bellone I, Rapacioli G, Putignano P. Clinical ...
  • Chen G, Lu F, Xu L, Dong H, Yi P, ...
  • Dai P, Wang J, Lin L, Zhang Y, Wang Z. ...
  • Wang Y, Huang Y, Lam KSL, Li Y, Wong WT, ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 8,078
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support